{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "6824708", "DateCompleted": {"Year": "1983", "Month": "04", "Day": "15"}, "DateRevised": {"Year": "2019", "Month": "06", "Day": "10"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0006-3002", "JournalIssue": {"Volume": "750", "Issue": "1", "PubDate": {"Year": "1983", "Month": "Jan", "Day": "07"}}, "Title": "Biochimica et biophysica acta", "ISOAbbreviation": "Biochim Biophys Acta"}, "ArticleTitle": "Characterization of phospholipase A2 activity in rat aorta smooth muscle cells.", "Pagination": {"StartPage": "134", "EndPage": "140", "MedlinePgn": "134-40"}, "Abstract": {"AbstractText": ["Phospholipase A activity was measured in homogenates and acid extracts of smooth muscle cells from rat aorta and mesenteric artery using [1-14 C]oleate-labeled autoclaved Escherichia coli and 1-[1-14C]stearyl-2-acyl-3-sn-glycerophosphorylethanolamine as substrates. The results demonstrate the presence of neutral-active phospholipase(s) A that exclusively catalyze the release of fatty acid from the 2-position of phospholipids. Optimal activity was at pH 7.5, and there was an absolute requirement for low concentrations of Ca2+. Mg2+ did not substitute for Ca2+, and EGTA inhibited the activity. Phospholipase A2 activity was predominantly membrane-associated and was solubilized by homogenization in 0.18 N H2SO4. Sulfuric acid extracts of rat aortic smooth muscle cells were four times more active than extracts of mesenteric artery (710 vs. 170 nmol/h per mg protein). By comparison, acid extracts of rat lung, heart, and liver were less active (60-75 nmol/h per mg). Indomethacin, sodium meclofenamate, mepacrine and chlorpromazine, but not dexamethasone or aspirin, inhibited acid-solubilized phospholipase(s) A2 between 10(-6) and 10(-3) M in a dose-dependent manner. Preincubation with p-bromophenacyl bromide or diethylpyrocarbonate inhibited phospholipase(s) A2, suggesting the presence of a histidine residue at the active site. An extract from the leaves of feverfew plant (Tanacetum parthenium) was also a potent inhibitor of aortic smooth muscle phospholipase(s) A2."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Thakkar", "ForeName": "J K", "Initials": "JK"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Sperelakis", "ForeName": "N", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Pang", "ForeName": "D", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Franson", "ForeName": "R C", "Initials": "RC"}], "GrantList": [{"GrantID": "HL-07244", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HL-19242", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HL-24907", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Biochim Biophys Acta", "NlmUniqueID": "0217513", "ISSNLinking": "0006-3002"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "EC 3.1.-", "NameOfSubstance": "Phospholipases"}, {"RegistryNumber": "EC 3.1.1.32", "NameOfSubstance": "Phospholipases A"}, {"RegistryNumber": "EC 3.1.1.4", "NameOfSubstance": "Phospholipases A2"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["enzymology"], "DescriptorName": "Aorta"}, {"QualifierName": [], "DescriptorName": "Hydrogen-Ion Concentration"}, {"QualifierName": [], "DescriptorName": "Kinetics"}, {"QualifierName": ["enzymology"], "DescriptorName": "Liver"}, {"QualifierName": ["enzymology"], "DescriptorName": "Lung"}, {"QualifierName": ["enzymology"], "DescriptorName": "Mesenteric Arteries"}, {"QualifierName": ["enzymology"], "DescriptorName": "Muscle, Smooth, Vascular"}, {"QualifierName": ["enzymology"], "DescriptorName": "Myocardium"}, {"QualifierName": [], "DescriptorName": "Organ Specificity"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phospholipases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phospholipases A"}, {"QualifierName": [], "DescriptorName": "Phospholipases A2"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Sesquiterpenes"}, {"QualifierName": [], "DescriptorName": "Tanacetum parthenium"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1983", "Month": "1", "Day": "7"}, {"Year": "1983", "Month": "1", "Day": "7", "Hour": "0", "Minute": "1"}, {"Year": "1983", "Month": "1", "Day": "7", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["6824708", "10.1016/0005-2760(83)90212-6", "0005-2760(83)90212-6"]}}]}